ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase I Dose Escalation Study of Biweekly Gemcitabine and Carboplatin in Completely Resected Stage IB-IIIA Nonsmall Cell Lung Cancer
American Journal of Clinical Oncology
◽
10.1097/01.coc.0000264179.23080.bc
◽
2007
◽
Vol 30
(5)
◽
pp. 498-502
◽
Cited By ~ 4
Author(s):
Yoshio Tomizawa
◽
Shin-ichi Ishihara
◽
Hironobu Iijima
◽
Hisao Imai
◽
Koji Sato
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Nonsmall Cell Lung Cancer
◽
Dose Escalation Study
◽
Stage Ib
◽
Resected Stage
Download Full-text
Related Documents
Cited By
References
A Phase I Dose Escalation Study of Weekly Docetaxel and Carboplatin in Elderly Patients With Nonsmall Cell Lung Cancer
American Journal of Clinical Oncology
◽
10.1097/01.coc.0000242292.17728.46
◽
2007
◽
Vol 30
(1)
◽
pp. 51-56
◽
Cited By ~ 6
Author(s):
Kyoichi Kaira
◽
Satoshi Tsuchiya
◽
Noriaki Sunaga
◽
Noriko Yanagitani
◽
Satoru Watanabe
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Phase I
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Nonsmall Cell Lung Cancer
◽
Dose Escalation Study
◽
Weekly Docetaxel
Download Full-text
Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/s0360-3016(03)01361-0
◽
2003
◽
Vol 57
(2)
◽
pp. S417-S418
◽
Cited By ~ 14
Author(s):
K.E Rosenzweig
◽
E Yorke
◽
A Jackson
◽
R Nayak
◽
V.W Rusch
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
Download Full-text
Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer
Journal of Radiation Research
◽
10.1093/jrr/rry058
◽
2018
◽
Vol 60
(2)
◽
pp. 228-233
Author(s):
Kyoichi Kaira
◽
Akihiro Ono
◽
Yosuke Kamide
◽
Noriaki Sunaga
◽
Yasuhiko Koga
◽
...
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Thoracic Radiation
Download Full-text
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-18-2014
◽
2018
◽
Vol 25
(2)
◽
pp. 496-505
◽
Cited By ~ 13
Author(s):
Florence Atrafi
◽
Harry J.M. Groen
◽
Lauren A. Byers
◽
Elena Garralda
◽
Martijn P. Lolkema
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Solid Tumors
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Extensive Stage
Download Full-text
Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer
Cancer
◽
10.1002/cncr.25473
◽
2010
◽
Vol 117
(4)
◽
pp. 809-818
◽
Cited By ~ 16
Author(s):
Karen Reckamp
◽
Barbara Gitlitz
◽
Lin-Chi Chen
◽
Ravi Patel
◽
Ginger Milne
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Nonsmall Cell Lung Cancer
◽
Pharmacodynamic Study
Download Full-text
Raltitrexed (‘Tomudex’) and cisplatin in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a Phase I dose-escalation study
European Journal of Cancer
◽
10.1016/s0959-8049(99)81422-1
◽
1999
◽
Vol 35
◽
pp. S253
◽
Cited By ~ 1
Author(s):
C. Manegold
◽
E. Buchholz
◽
R. Kloeppel
◽
C. Kreisel
◽
M. Smith
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Preliminary Results
Download Full-text
Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer
Medicine
◽
10.1097/md.0000000000000903
◽
2015
◽
Vol 94
(22)
◽
pp. e903
◽
Cited By ~ 14
Author(s):
Jiaxi He
◽
Jianfei Shen
◽
Chenglin Yang
◽
Long Jiang
◽
Wenhua Liang
◽
...
Keyword(s):
Lung Cancer
◽
Adjuvant Chemotherapy
◽
Cell Lung Cancer
◽
Nonsmall Cell Lung Cancer
◽
Stage Ib
◽
Resected Stage
Download Full-text
Ensartinib (X-396), a second-generation ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation study.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.e21122
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. e21122-e21122
◽
Cited By ~ 2
Author(s):
Wenfeng Fang
◽
Yuxiang Ma
◽
Jianjin Huang
◽
Yang Zhang
◽
Benyan Zou
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Second Generation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Alk Positive
Download Full-text
Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer
International Journal of Clinical Oncology
◽
10.1007/s10147-015-0883-7
◽
2015
◽
Vol 21
(2)
◽
pp. 240-247
◽
Cited By ~ 2
Author(s):
Kyoichi Kaira
◽
Noriaki Sunaga
◽
Hisao Imai
◽
Yosuke Kamide
◽
Yasuhiko Koga
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Previously Treated
Download Full-text
9163 Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71876-2
◽
2009
◽
Vol 7
(2)
◽
pp. 554
Author(s):
L. Teixeira
◽
R. Descourt
◽
D. Moro-Sibilot
◽
J.L. Misset
◽
E. Gachard
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close